Abstract:Abstract A well-established preclinical model of pancreatic cancer needs to be established to facilitate research on new therapeutic targets. Recently established animal models of pancreatic cancer, including patient-derived tumor models and organoid models, are used for pre-clinical drug testing and biomarker discovery. These models have useful characteristics over conventional xenograft mouse models based on cell lines in preclinical studies, but still cannot accurately predict the clinical outcomes of new treatments and have not yet been broadly implemented in research. We employed pancreatic cancer organoid culture methods using the pancreatic cancer cell line S2-013, and performed pathological and immunohistochemical analyses to characterize tumor xenografts obtained from a mouse model implanted with S2-013 cell line-derived organoids. Serum levels of the pancreatic cancer tumor marker CA19-9 were measured by ELISA. We generated human pancreatic cancer organoids using a co-culture of S2-013 cells, human endothelial cells derived from human umbilical vein endothelial cells, and human mesenchymal stem cells, and established a mouse model with subcutaneously transplanted human pancreatic cancer organoids (S2-013-organoid model). Although blood clotting crater-like formation developed in the middle of subcutaneous xenografts in the S2-013-conventional model, created by subcutaneously injecting S2-013 cells into the right flank of nude mice, the size of xenografts in the S2-013-organoid model gradually increased without crater-like formation. Importantly, tumor xenografts obtained from the S2-013-organoid model exhibited a clinical human pancreatic cancer tissue-like cellular morphology, tissue architecture, and polarity, and actively formed cancer stroma containing mature blood vessels with the high expression of the vascular tight junction marker CD31. In subcutaneous xenografts of S2-013-conventional mice, no blood vessel density or widely expanding areas of necrotic regions were present. Consequently, serum levels of CA19-9 in the S2-013-organoid model correlated with tumor volumes. In addition, epithelial–mesenchymal transition, the conversion of epithelial cells to the mesenchymal phenotype, was observed in tumor xenografts of the S2-013-organoid model. The S2-013-organoid model provides tumor xenografts consisting of clinical human pancreatic cancer-like tissue formation with the effective development of vascularized stroma, and may be valuable for facilitating studies on pre-clinical drug testing and biomarker discovery.

Establishment of No. 2 Implanted Tumor Model of Human Cholangiocarcinoma in Nude Mice

Establishment of Nude Mouse Model of Human Prostate Carcinoma by Subcutaneous Injection of Cell Line LNCaP

Construction of mouse model of liver implanted tumor after hepatectomy

Establishment of human hilar cholangiocarcinoma orthotopic tumor model in nude mice

Establishment of a Metastatic Model of Human Hepatocellular Carcinoma in Nude Mice Via Orthotopic Implantation of Histologically Intact Tissues

Establishment of NOD/SCID Mouse Models of Human Hepatocellular Carcinoma Via Subcutaneous Transplantation of Histologically Intact Tumor Tissue.

TRANSPLANTATION OF HUMAN HEPATOCELLULAR CARCINOMA IN NUDE MICE I. ESTABLISHMENT OP MODEL AND ITS SEROLQGICAL AND MORPHOLOGICAL FEATURES

Establishment and characterization of human colorectal cancer orthotopic implantation model in nude mice

Establishment and Characterization of a Nude Mouse Model of Subcutaneously Implanted Tumors and Abdominal Metastasis in Gastric Cancer

Establishment of Human Colorectal Cancer Postoperative Metastasis Model in Nude Mice

Establishment of a H22 Implanted Advanced Hepatocellular Carcinoma Model of Mice

Establishment of an Orthotopic Transplantation Tumor Model of Hepatocellular Carcinoma in Mice.

Establishment of Orthotopic Transplantation tumor and metastasis Model of Human Colorectal Tumor in Nude Mice

A Nude Mouse Model of Orthotopic Liver Transplantation of Human Hepatocellular Carcinoma HCCLM3 Cell Xenografts and the Use of Imaging to Evaluate Tumor Progression

Establishment of an Orthotopic Transplantation Model of Human Hepatocellular Carcinoma in NOD-SCID Mice and Its Biological Characteristics

Metastatic Human Hepatocellular Carcinoma Models in Nude Mice and Cell Line with Metastatic Potential

Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid

Establishment of a Transplanted Tumor Model of Human Oral Squamous Cell Carcinoma in Nude Mice

Establishment of Orthotopic Transplantation Nude Mouse Model with Pancreatic Cancer Celllines CFPAC

Preliminary Observation on Biological Characteristics of Gallbladder Carcinoma Subcutaneous Tumor Model in Nude Mice

Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6